The deal will broaden AngioDynamics' oncology business, adding RadiaDyne's OARtrac radiation dose monitoring platform to its portfolio, the company said. RadiaDyne also makes IsoLoc/ImmobiLoc, endorectal tools that reduce prostate motion and radiation toxicity, and Alatus, a vaginal balloon packing system that improves dosimetry, according to AngioDynamics.
RadiaDyne's 12-month revenues exceeded $6 million. The acquisition is expected to close by the end of September, AngioDynamics said.
Copyright © 2018 AuntMinnie.com